380 related articles for article (PubMed ID: 38511067)
21. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.
Ying L; Chen Q; Wang Y; Zhou Z; Huang Y; Qiu F
Mol Biosyst; 2012 Sep; 8(9):2289-94. PubMed ID: 22722759
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins.
Fang Z; Zhang S; Wang Y; Shen S; Wang F; Hao Y; Li Y; Zhang B; Zhou Y; Yang H
BMC Cancer; 2016 Sep; 16(1):706. PubMed ID: 27586393
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
Wu J; Weng Y; He F; Liang D; Cai L
Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
[TBL] [Abstract][Full Text] [Related]
24. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
[TBL] [Abstract][Full Text] [Related]
25. The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
Zhou Y; Xu X; Lv H; Wen Q; Li J; Tan L; Li J; Sheng X
PLoS One; 2016; 11(5):e0155250. PubMed ID: 27227769
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MALAT 1/miR-625-3p/HIF-1α axis regulates the EMT of hypoxia-induced RPE cells by activating NF-κB/snail signaling.
Zou L; Wang X; Han X
Exp Cell Res; 2023 Aug; 429(1):113650. PubMed ID: 37209990
[TBL] [Abstract][Full Text] [Related]
27. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
28. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.
Schmidt LH; Spieker T; Koschmieder S; Schäffers S; Humberg J; Jungen D; Bulk E; Hascher A; Wittmer D; Marra A; Hillejan L; Wiebe K; Berdel WE; Wiewrodt R; Muller-Tidow C
J Thorac Oncol; 2011 Dec; 6(12):1984-92. PubMed ID: 22088988
[TBL] [Abstract][Full Text] [Related]
29. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
30. Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis.
Wang Y; Zhang Y; Hu K; Qiu J; Hu Y; Zhou M; Zhang S
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32700729
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
Huang JL; Liu W; Tian LH; Chai TT; Liu Y; Zhang F; Fu HY; Zhou HR; Shen JZ
Oncol Rep; 2017 Sep; 38(3):1353-1362. PubMed ID: 28713913
[TBL] [Abstract][Full Text] [Related]
32. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract][Full Text] [Related]
33. MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer.
Barsoum FS; Awad AS; Hussein NH; Eissa RA; El Tayebi HM
Pathol Res Pract; 2020 Dec; 216(12):153274. PubMed ID: 33171372
[TBL] [Abstract][Full Text] [Related]
34. Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1.
Kan JY; Wu DC; Yu FJ; Wu CY; Ho YW; Chiu YJ; Jian SF; Hung JY; Wang JY; Kuo PL
J Cell Physiol; 2015 Aug; 230(8):1883-94. PubMed ID: 25546229
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
36. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
37. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.
Guo Y; Xie Y; Luo Y
Front Immunol; 2022; 13():851004. PubMed ID: 35222443
[TBL] [Abstract][Full Text] [Related]
38. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis.
Xu C; Yang M; Tian J; Wang X; Li Z
Int J Oncol; 2011 Jul; 39(1):169-75. PubMed ID: 21503572
[TBL] [Abstract][Full Text] [Related]
39. The long noncoding RNA MALAT-1 functions as a competing endogenous RNA to regulate MSL2 expression by sponging miR-338-3p in myasthenia gravis.
Kong X; Wang J; Cao Y; Zhang H; Lu X; Wang Y; Bo C; Wang T; Li S; Tian K; Liu Z; Wang L
J Cell Biochem; 2019 Apr; 120(4):5542-5550. PubMed ID: 30362606
[TBL] [Abstract][Full Text] [Related]
40. MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.
Jin J; Fu L; Hong P; Feng W
Acta Biochim Pol; 2023 Feb; 70(1):37-43. PubMed ID: 36812496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
